Key result
Chronic hypertensive states consistently manifest renal or adrenal alterations, leading to arteriolosclerotic changes, parenchymal degeneration, and stromal fibrosis.
Provides a narrative overview of the pathologic renal and adrenal alterations associated with chronic hypertension.
Answers are grounded in this paper and cite their sources.
Supports BP control to limit renal-adrenal fibrosis; leaves open reversal strategies for prospective trials.
ALL chronic hypertensive states in human subjects manifest some renal or adrenal alterations, or both. Persistently elevated systemic blood pressures damage the delicate intrarenal and periadrenal arterioles to produce the familiar arteriolosclerotic changes and eventually varying degrees of parenchymal degeneration and atrophy with stromal fibrosis result. More cogent diagnostic and therapeutic problems than those provided by renal and adrenal lesions secondary to chronic hypertension are (1) the relatively uncommon primary renal or adrenal abnormalities responsible for increased blood pressures and (2) the renal or adrenal alterations that may secondarily exaggerate or maintain any hypertensive state. Primary Renal Hypertension Goldblatt's renal arterial clamping experiments are mirrored by the natural human condition in which either parts or all of one or both kidneys are served by stenotic renal arteries.1Quantitative determinations have not been made of the precise range of cross-sectional narrowing required to set off the Goldblatt mechanism. Usually the
No takes yet. Share an insight, caveat, or question.
Sheldon C. Sommers (1961) conducted a review in Renal and Adrenal Hypertension. Chronic hypertensive states consistently manifest renal or adrenal alterations, leading to arteriolosclerotic changes, parenchymal degeneration, and stromal fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: